SunTrust Robinson Humphrey Downgrades ARIAD Pharmaceuticals (ARIA) to Hold
Tweet
Share
E-mail
Get Alerts ARIA Hot Sheet
Price: $25.17 +1.57%
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 10 | New: 18
Join SI Premium – FREE
SunTrust Robinson Humphrey downgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from Buy to Hold with a price target of $24.00.
For an analyst ratings summary and ratings history on ARIAD Pharmaceuticals click here. For more ratings news on ARIAD Pharmaceuticals click here.
Shares of ARIAD Pharmaceuticals closed at $23.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Nichirei Corp (2871:JP) to Equalweight
- UBS Downgrades IDP Education (IEL:AU) (IDPUF) to Neutral
- Citi Downgrades Coles Group Ltd. (COL:AU) (CLEGF) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
